A Food-Grade, Secretory Expression of IL1RA Protein in a Lactococcus Lactis System for Potential Oral Therapy on IBD
- Jin CHENG, Jin CAO, Jia CAO, Xiao-feng WANG, Yan-ru GE
- Corresponding Author
- Jin CHENG
Available Online May 2017.
- https://doi.org/10.2991/bbe-17.2017.61How to use a DOI?
- Interleukin 1 receptor antagonist (IL1RA), Lactococcus lactis, Recombinant, Inflammatory bowel disease (IBD).
- Interleukin 1 (IL1 ) is a potential target for IBD treatment. IL1 receptor antagonist (IL1RA) can blocks the biologic activity of IL1 by competitively inhibiting IL1 binding to the IL1R, so IL1RA is suggested to have possible therapeutic applications in treatment of IBD. By using a food-grade recombinant Lactococcus lactis system, a constitutive expression vector IL1RA:pNZ8149 was constructed and transferred into a L. lactis host NZ3900 in this study. The engineered strain was fermented and detected by colonies PCR and Western blot, the results indicate that the IL1RA secretory expression can be archived by IL1RA/NZ3900.
- Open Access
- This is an open access article distributed under the CC BY-NC license.
Cite this article
TY - CONF AU - Jin CHENG AU - Jin CAO AU - Jia CAO AU - Xiao-feng WANG AU - Yan-ru GE PY - 2017/05 DA - 2017/05 TI - A Food-Grade, Secretory Expression of IL1RA Protein in a Lactococcus Lactis System for Potential Oral Therapy on IBD BT - 2nd International Conference on Biomedical and Biological Engineering 2017 (BBE 2017) PB - Atlantis Press SN - 2468-5747 UR - https://doi.org/10.2991/bbe-17.2017.61 DO - https://doi.org/10.2991/bbe-17.2017.61 ID - CHENG2017/05 ER -